January 09, 2025 09:53 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes | Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her
UN health agency to examine lower-cost ‘biosimilar’ drugs to expand access to cancer treatment

UN health agency to examine lower-cost ‘biosimilar’ drugs to expand access to cancer treatment

May 05, 2017, at 09:33 pm

New York, May 5 (Just Earth News): As a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries, the World Health Organization (WHO) said on Thursday that it will launch a pilot project for prequalifying so-called “biosimilars,” or lower cost drugs.